175 related articles for article (PubMed ID: 36310535)
1. Operation of the anti-doping laboratory for the Beijing 2022 Olympic and Paralympic Winter Games.
Wang Y; Zhang L; Xing Y
Drug Test Anal; 2022 Nov; 14(11-12):1853-1863. PubMed ID: 36310535
[TBL] [Abstract][Full Text] [Related]
2. Preparation and accreditation of anti-doping laboratories for the Olympic Games.
Botrè F; Wu M; Boghosian T
Bioanalysis; 2012 Jul; 4(13):1623-31. PubMed ID: 22831478
[TBL] [Abstract][Full Text] [Related]
3. Doping control analyses during the Tokyo 2020 Olympic and Paralympic Games.
Okano M; Ikekita A; Sato M; Inoue T; Kageyama S; Akiyama K; Aoi A; Miyamoto A; Momobayashi A; Ota M; Ishige M; Sakurai H; Shiomura S; Takemine M; Watanabe Y; Hikota T
Drug Test Anal; 2022 Nov; 14(11-12):1836-1852. PubMed ID: 36208085
[TBL] [Abstract][Full Text] [Related]
4. Investigation of supplement use and knowledge among Japanese elite athletes for the Tokyo 2020 Olympic/Paralympic games and the Beijing 2022 winter Olympic/Paralympic games.
Myoenzono K; Yasuda J; Takai E; Shinagawa A; Kaneko N; Yoshizaki T; Namma-Motonaga K; Yoshino M; Kondo E; Nakajima K; Hangai M; Kamahara K; Kamihigashi E; Kusano S; Kamei A
Front Sports Act Living; 2023; 5():1258542. PubMed ID: 37927448
[TBL] [Abstract][Full Text] [Related]
5. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.
Sobolevsky T; Krotov G; Dikunets M; Nikitina M; Mochalova E; Rodchenkov G
Drug Test Anal; 2014; 6(11-12):1087-101. PubMed ID: 25312500
[TBL] [Abstract][Full Text] [Related]
6. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
Stuart M; Kwon YI; Rhie SJ
Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
[TBL] [Abstract][Full Text] [Related]
7. Development and application of PyeongChang 2018 Winter Olympic and Paralympic Games Accessibility Manual.
Lee HL; Kim JY; Kim JB
Disabil Rehabil Assist Technol; 2021 May; 16(4):391-397. PubMed ID: 32419539
[TBL] [Abstract][Full Text] [Related]
8. Interview: partnering with the industry: the Olympic laboratory model.
Cowan DA; Barker CP
Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471
[TBL] [Abstract][Full Text] [Related]
9. The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
McCloskey B; Saito T; Shimada S; Ikenoue C; Endericks T; Mullen L; Mota P; Kumar CK; Laxminarayan R; Budgett R; Heymann D; Zumla A
Lancet; 2024 Feb; 403(10425):493-502. PubMed ID: 38244561
[TBL] [Abstract][Full Text] [Related]
10. [Anesthesia management of athletes' operation in Beijing Olympic Winter Games].
Kang ZY; Wang LL; Han YZ; Guo XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):770-773. PubMed ID: 35950407
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology in the Olympic Winter Games and Beyond.
He C; Cao M; Liu J; Ge Z; Zhou R; Xu H
ACS Nano; 2022 Apr; 16(4):4981-4988. PubMed ID: 35416645
[TBL] [Abstract][Full Text] [Related]
12. Doping control analysis at the Rio 2016 Olympic and Paralympic Games.
Pereira HMG; Sardela VF; Padilha MC; Mirotti L; Casilli A; de Oliveira FA; de Albuquerque Cavalcanti G; Rodrigues LML; de Araujo ALD; Levy RS; Teixeira PAC; de Oliveira FAG; Duarte ACG; Carneiro ACD; Evaristo JAM; Dos Santos GRC; da Costa GCV; de Lima Castro F; Nogueira FCS; Scalco FB; Pizzatti L; de Aquino Neto FR
Drug Test Anal; 2017 Nov; 9(11-12):1658-1672. PubMed ID: 29078043
[TBL] [Abstract][Full Text] [Related]
13. Influence of Beijing Winter Olympic Games Construction on Vegetation Coverage around Zhangjiakou Competition Zone.
Zhang Y; Xu Z; Wu J
Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886500
[TBL] [Abstract][Full Text] [Related]
14. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
[TBL] [Abstract][Full Text] [Related]
15. Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based study.
Kong L; Duan M; Shi J; Hong J; Zhou X; Yang X; Zhao Z; Huang J; Chen X; Yin Y; Li K; Liu Y; Liu J; Wang X; Zhang P; Xie X; Li F; Chang Z; Zhang Z
Infect Dis Poverty; 2022 Sep; 11(1):95. PubMed ID: 36068625
[TBL] [Abstract][Full Text] [Related]
16. Home advantage in the Winter Paralympic Games 1976-2014.
Wilson D; Ramchandani G
Sport Sci Health; 2017; 13(2):355-363. PubMed ID: 28804521
[TBL] [Abstract][Full Text] [Related]
17. Case study of the Beijing 2022 Olympic Winter Games: Implications for global mass gathering events amidst the COVID-19 pandemic.
Huo D; Shen Y; Zhou T; Yu T; Lyu R; Tong Y; Gao T; Wang Q
Front Public Health; 2023; 11():1068023. PubMed ID: 36815167
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Investigation of supplement use and knowledge among Japanese elite athletes for the Tokyo 2020 Olympic/Paralympic Games and the Beijing 2022 Winter Olympic/Paralympic Games.
Myoenzono K; Yasuda J; Takai E; Shinagawa A; Kaneko N; Yoshizaki T; Namma-Motonaga K; Yoshino M; Kondo E; Nakajima K; Hangai M; Kamahara K; Kamihigashi E; Kusano S; Kamei A
Front Sports Act Living; 2023; 5():1338039. PubMed ID: 38094085
[TBL] [Abstract][Full Text] [Related]
19. Team USA injury and illness incidence at the 2022 Beijing Winter Olympic and Paralympic Games.
Anderson T; Cali MG; Clark SC; Hasley I; Larson EG; Noble-Taylor KE; Robinson DM; Post E; Finnoff JT; Adams WM
Br J Sports Med; 2023 Oct; ():. PubMed ID: 37890965
[TBL] [Abstract][Full Text] [Related]
20. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio.
Athanasiadou I; Voss S; Lyris E; Aljaber A; Alsayrafi M; Georgakopoulos C
Bioanalysis; 2016 Nov; 8(21):2265-2279. PubMed ID: 27665839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
